Navigation Links
Catholic Health Association Applauds HHS Decision on Plan B
Date:12/9/2011

WASHINGTON, Dec. 9, 2011 /PRNewswire-USNewswire/ -- Sister Carol Keehan, DC, president and chief executive officer of the Catholic Health Association of the United States (CHA), issued the following statement.

The Catholic Health Association is very grateful to HHS Secretary Kathleen Sebelius for her intelligent and courageous decision to prevent very young adolescents from purchasing and administering unsupervised the strong hormone contained in the drug known as Plan B.

There is grave concern about the safety of very young adolescents self-administering this hormone at such a critical time in their growth cycle. This is not a case of politics versus science. There is no strong science that definitively establishes the safety of this drug when self-administered by 11- and 13-year olds. 

CHA has great respect for the FDA, but there are no significant studies in 11 to 13-year olds over a long period of time that have demonstrated the safety of this very significant drug. We do not want to learn in 10 to 20 years about this drug what we now know about hormone replacement therapy and its connection to breast cancer. In addition, there are no long term studies that demonstrate the drug's potential impact on future reproductive choices these young girls will make.

Our country must help parents exercise their responsibility to their children. Giving parents control over relatively inconsequential areas such as ear-piercing and then taking it away in such a serious area would not only put their children at risk but undermine parents' ability to parent. This great country is built on the strength of the family and this decision helps to maintain a strong role for parents in critical decisions. 

The Catholic Health Association of the United States (CHA), founded in 1915, supports the Catholic health ministry's commitment to improve the health status of communities and create quality and compassionate health care that works for everyone. The Catholic health ministry is the nation's largest group of not-for-profit health systems and facilities that, along with their sponsoring organizations, employ more than 750,000 women and men who deliver services combining advanced technology with the Catholic caring tradition. For more information, visit the CHA website at www.chausa.org.


'/>"/>
SOURCE Catholic Health Association of the United States
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy, Inc. Receives Purchase Orders from Catholic Health Initiatives for its MammoView(TM) Product Line
2. Michigan Catholic Conference Welcomes Announcement of Non-Embryo Destructive Stem Cell Research Advancement
3. HeartWare to Present at the Oppenheimer 22nd Annual Healthcare Conference
4. Lilly for Better Health™ Expands Website to Include Spanish Health Information and Interactive Tools
5. OncoSec to Present at the 22nd Annual Oppenheimer Healthcare Conference
6. IBM Contributes Data to the National Institutes of Health to Speed Drug Discovery and Cancer Research Innovation
7. Arena Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference
8. Genomic Health Announces Positive Results of First Clinical Outcomes Study for Biomarker Discovery Using Next Generation Sequencing at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
9. Nicotinic Acid: The Key Ingredient in Niacin Dietary Supplements that Supports Heart Health
10. Verinata Health Announces New Corporate Headquarters and Expanded Laboratory Operations
11. Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... , ... "FCPX editors can now reveal their media with growing colorful split ... Austin - CEO of Pixel Film Studios. , ProSlice Color brings the split ... now reveal the media of their split screens with growing colorful panels. , ProSlice ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
Breaking Medicine News(10 mins):